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Abstract 
Background: Reducing hospitalisation and length of stay (LOS) in hospital following first 
episode psychosis (FEP) is important, yet reliable measures of these outcomes and their 
moderators are lacking. We conducted a systematic review and meta-analysis to investigate 
the proportion of FEP cases who were hospitalised after their first contact with services and 
the LOS in hospital during follow-up. 
Methods: Studies were identified from a systematic search across major electronic databases 
from inception to October 2017. Random effects meta‐analyses and meta‐regression 
analyses were conducted. 
Results: 81 longitudinal studies encompassing data for 23280 FEP patients with an average 
follow-up length of 7 years were included. 55% (95%CI=50.3-60.5%) of FEP cases were 
hospitalised at least once during follow-up with the pooled average LOS of 116.7 days 
(95%CI=95.1-138.3). Older age of illness onset and being in a stable relationship were 
associated with a lower proportion of people who were hospitalised. While the proportion of 
hospitalised patients has not decreased over time, LOS has, with the sharpest reduction in 
the latest time period. The proportion of patients hospitalised during follow-up was highest in 
Australia and New Zealand (78.4%) compared to Europe (58.1%) and North America (48.0%); 
and lowest in Asia (32.5%). Black ethnicity and longer duration of untreated psychosis were 
associated with longer LOS; while less severe psychotic symptoms at baseline were 
associated with shorter LOS.  
Conclusion: One in two FEP cases required hospitalisation at least once during a 7-year 
follow-up with an average length of hospitalisation of 4 months during this period. LOS has 
declined over time, particularly in those countries in which it was previously longest. 
Key words: First episode psychosis / schizophrenia / hospitalisation / length of stay / inpatient 
/ follow-up / outcome 
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Introduction 
Psychotic disorders are a major cause of morbidity and premature mortality affecting 
approximately 3% of the general population (van Os et al., 2009). They are associated with a 
significant public health burden worldwide (Knapp et al., 2004) with approximately half of the 
costs attributable to hospitalisation (Kennedy et al., 2014; Sledge et al., 1996).  
Even though hospitalisation for psychosis has been a common outcome measure in 
longitudinal studies for the past 40 years, it remains unclear how many patients require 
hospital admission in the years after FEP. Some studies have reported that 30% or fewer 
patients with FEP are hospitalised at least once during their illness course (Salem et al., 2009; 
Stirling et al., 2003; Ucok et al., 2006) while others found that as many as 90% required 
hospital care after their first contact with mental health services (Berge et al., 1983; Lehtinen 
et al., 2000). Similarly, wide variations in the length of stay (LOS) in psychiatric inpatient units 
have been reported with average durations ranging from 20 days to 740 days (Fraguas et al., 
2014; Turner et al., 2009). Methodological variations accounting for some of this heterogeneity 
preclude the development of a reliable picture of hospital use in patients after FEP (Eaton et 
al., 1992). There is also the question of the generalisability of studies as a large proportion 
were conducted in high-income counties (Patel et al., 2007; Saxena et al., 2006). Thus, the 
current depiction of illness course is driven by findings obtained in the countries that are known 
for superior health-care rather than being globally representative.  
It is important to provide unbiased and generalisable estimates of how many FEP 
cases will require hospitalisation after their first contact with services and of the time they will 
spend in inpatient care during their illness course. This will contribute to a better understanding 
of treatment needs for these individuals and aid service development and planning (Friis et 
al., 2016). It is equally important to identify moderating factors for these outcomes which may 
help to identify those FEP cases who may be at greater risk of poor long-term outcomes (Friis 
et al., 2016; Lally & Gaughran, 2018). However, no previous study has conducted a meta-
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analysis incorporating global data and considered the moderators of hospital admission and 
LOS with meta-regression, which may identify important variables that influence these 
outcomes.  
Therefore, the aims of the study were to conduct a systematic review and meta-
analysis of all longitudinal studies that investigated the proportion of people with FEP who 
were hospitalised at least once during follow-up and/or reported average LOS during this 
period; and further to identify the moderators for these outcomes. Given the drive to reduce 
LOS and hospital admission, we hypothesised that the number of patients who required 
inpatient care, and the average LOS during follow-up would be significantly lower in the studies 
conducted in the last 20 years compared to earlier studies. 
 
Methods 
This systematic review was conducted and reported according to the Meta-analysis of 
Observational Studies in Epidemiology guidelines (Stroup et al., 2000) and the Preferred 
Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) (Moher et al., 2009).  
 
Search Strategy  
Two independent authors (JL, OA) searched PubMed, Medline, and Scopus without 
language restrictions from database inception to 1st October 2017. Key words used were (“first 
episode psychosis” OR “early episode psychosis” OR “FEP” OR “schizophrenia” OR “schiz*”) 
AND (“admission” OR “hospitalisation” OR “hospitalization” OR “hospital*” AND “outcome” OR 
“follow-up”). A manual search of the reference lists of the retrieved articles was conducted.  
Articles were initially screened based on title and abstract. The full texts of potentially 
eligible articles were independently inspected by two of the authors (O.A., J.L.). When data 
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were incomplete, the corresponding author was contacted and invited to send additional 
information. When studies reported on overlapping samples, details of the study with the 
longest follow-up were included. If this was unclear, studies with the largest study sample for 
each respective outcome were included. We included multi-site studies and retained data for 
the entire cohort and not for individual sites.  
 
Inclusion and exclusion criteria  
We included longitudinal studies, incorporating both retrospective and prospective study 
designs, which were conducted in patients with FEP (including first episode schizophrenia and 
first episode affective psychosis) irrespective of clinical setting (i.e., inpatient, outpatient or 
mixed) that fulfilled the following criteria: 1) studies reporting the a) proportion of patients who 
were hospitalised at least once during the follow-up period; and b) average LOS in psychiatric 
hospitals during the entire follow-up period; 2) studies including individuals with FEP who were 
making their first contact with mental health services for psychosis; 3) studies using a specified 
standardised diagnostic system (e.g., International Classification of Diseases (ICD versions 8, 
9 and 10), Diagnostic and Statistical Manual of Mental Disorders (DSM versions III and IV), 
and the Research Diagnostic Criteria (RDC); 4) studies with a follow-up period ≥12 months; 
and 5) English language articles published in peer-reviewed journals.  
We excluded studies if they: 1) were Randomised Control Trials, due to the potential 
that any structured intervention beyond routine care could influence the primary outcomes 
outlined in this meta-analysis; 2) assessed the feasibility and effectiveness of different 
treatment strategies for psychotic disorders; 3) were of organic psychosis due to medical 
conditions (i.e psychosis secondary to medical condition, such as encephalitis or epilepsy) or 
non-FEP cohorts; and 4) did not report quantitative data;  
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Data Extraction 
Three authors (J.L., O.A., E.F.) extracted all data using a predetermined data 
extraction form and any inconsistencies were resolved by consensus. The data extracted 
included first author, study participant details, including mean age (years) at illness onset and 
first contact with mental health services, gender, country, setting (i.e., inpatient, outpatients 
(community), mixed, in- and out-patient settings), population, study design (i.e., prospective, 
retrospective), diagnostic classification method, assessment type, economic income status of 
the countries, duration of untreated psychosis (DUP), socio-demographic characteristics of 
the sample at the time of recruitment (i.e., proportion of patients who were employed, single 
or in a stable relationship at the study entry), baseline psychotic symptoms (mean scores), 
length of study follow-up, attrition, proportion hospitalised and average LOS, the proportion of 
patients who were taking antipsychotic medications at the study entry and at the end of follow-
up, compliance with antipsychotic medications during the follow-up period, and socio-
demographic characteristics at the end of follow-up (i.e., proportion of patients who were 
employed, single or in a stable relationship at the end of the follow-up period). A more detailed 
definition of these variables is provided in Supplementary Materials.  
 
Definitions of outcomes 
The co-primary outcomes were:  
1. the proportion of people with FEP who were hospitalised at least once during the 
follow-up period (excluding any hospitalisation which occurred during the first contact 
for FEP) 
2. the average LOS in psychiatric hospitals defined as the average (mean and the 
standard deviation measured in days) time spent in hospital during the follow-up period 
excluding any hospitalisation which occurred during the first contact for FEP.  
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Statistical analysis 
All analysis was conducted with Comprehensive Meta-Analysis software (CMA, Version 
3) and RStudio version 3.4.4 (Integrated Development for R. RStudio, Inc., Boston). The 
pooled prevalence of hospitalisation and average LOS was calculated using a random-effects 
model (Borenstein et al., 2010). The random-effects model was chosen to account for the 
influence of the context of care on these outcomes. To examine potential effects of specific 
factors on the primary outcomes, we further stratified these analyses according to: 1) baseline 
diagnosis, 2) assessment types; 3) length of follow-up; 4) study region; 5) study settings, and 
6) economic income status of the country in which the study was conducted. The summary 
statistics were illustrated with a forest plot and funnel plot (Duval et al., 2000; Phan et al., 
2014). 
To investigate the variables that may influence the outcomes we conducted an 
unrestricted maximum likelihood meta-regression. The included moderating factors were age 
at illness onset, age at first contact with mental health services, male gender, ethnicity, 
baseline psychotic symptoms (mean scores), relationship and employment status at baseline, 
DUP, duration of follow-up, attrition rate, study year, treatment with antipsychotic medications 
at baseline and during follow-up, and compliance with antipsychotic medications during the 
entire follow-up period.  
Publication bias was assessed with the funnel plot, Egger regression test (Opjordsmoen 
et al., 2010). We also adjusted for the presence of any publication bias calculating the Duval 
and Tweedie “trim-and-fill” method (Tohen et al., 1992). Heterogeneity was measured with the 
Q statistic yielding a chi-square and p-value, and the I2 statistic with scores above 50% and 
75% indicating moderate and high heterogeneity, respectively (Higgins et al., 2003). Statistical 
significance was considered to be at or below the 0.05 level.  
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Results 
Search results and included participants  
The flowchart of the article selection process is depicted in Figure 1 and descriptive 
characteristics of each study are outlined in Supplementary Table 1. The search yielded 1434 
non-duplicated publications, which were considered at the title and abstract level; 382 of these 
were extracted for full text review, of which 81 met the inclusion criteria with a total sample of 
23280 FEP patients (range=20-12071). The mean age at illness onset in these studies was 
23.5 years (SD=5.7), while mean age at first contact with mental health services was 27.3 
year (SD=64); 42.3% were female and 59.3% had a baseline diagnosis of first episode 
schizophrenia.  
 
Meta-analysis of hospitalisation  
The proportion of people with FEP who were hospitalised at least once during the follow-
up, together with heterogeneity and trim-and-fill analyses, is presented in Table 1. In total, 60 
studies reported on the number of people with FEP who were hospitalised at least once during 
the follow-up period. Average length of follow-up across these studies was 7.6 years (SD=6.1, 
interquartile range (IQR)=2-11.8). The total sample at the end of the follow-up period was 
19675 FEP cases (range=20-12071, IQR=47-149). The pooled proportion of hospitalised FEP 
patients during follow-up was 55.4% (95%CI=50.3-60.5, Q=3575.1, I2=98.5). The Begg-
Mazumdar (Kendall's tau b=-0.005, P=0.957) and Egger test (t=-2.53, df=56, p=0.014) 
indicated no publication bias.  
 
Subgroup analyses of hospitalisation  
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Stratified proportions of FEP patients who were hospitalised at least once during the 
follow-up period, together with heterogeneity and trim-and-fill analyses are presented in Table 
1. The proportion of patients hospitalized during follow-up was significantly higher in studies 
from Australia and New Zealand (78.4%, 95%CI=59.2-97.5, I2=98.4, Q=203.7) compared to 
studies from Europe (58.1%, 95%CI=50.7-65.5, I2=97.1, Q=1212.1) and North America 
(48.0%, 95%CI=34.5-61.6, I2=95.4, Q=213.6); the lowest proportion of hospitalised patients 
was reported in studies from Asia (32.5%, 95%CI=25.3-41.4, I2=81.4, Q=39.7). The pooled 
proportion of hospitalised patients during follow-up was highest in studies which were 
conducted in high-income countries (57.9%, 95%CI=51.7-64.1, I2=98.4, Q=2833.6) compared 
with studies conducted in middle-income countries (34.8%, 95%CI=20.0-49.6, I2=96.0, 
Q=355.8). The trim-and-fill method demonstrated that the proportion of patients who required 
hospitalisation at least once during the follow-up period in the middle-income countries was 
42.9% (95%CI=27.4-56.5) when adjusted for potentially missing studies. There were no 
studies from low-income countries. 
 
Effect of moderator variables influencing hospitalisation  
Full details of the moderators of hospitalisation during the follow-up period are presented 
in Table 2. A lower proportion of hospitalised patients during follow-up was associated with 
an older age of illness onset (β=-0.049, 95%CI=-0.092 - -0.005, p=0.028, R2=0.07) and having 
a stable relationship at baseline (β=-0.011, 95%CI= -0.018 - -0.004, p=0.004, R2=0.33). There 
was a trend association between Black ethnicity and increased hospitalisation (β=0.004, 
95%CI=0.000-0.009, p=0.075, R2=0.13), and between higher loss to attrition and reduced 
hospitalisation during follow-up (β=-0.003, 95%CI=-0.007-0.000, p=0.080, R2=0.04).  
 
Meta-analysis of LOS 
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Average LOS across the follow-up period with heterogeneity and trim-and-fill analyses 
is provided in Table 3. In total, 37 studies reported on LOS over the follow-up period. The 
average LOS was 176.8 days (SD=186.7, median=106 days, IQR=76-204 days). Average 
length of follow-up across these studies was 7 years (mean=6.6 years, SD=6.4, IQR 2-8) with 
a cumulative sample of 4877 FEP cases (range=20-720, IQR=43.5-191.5). The pooled 
average LOS across the entire follow-up period was 116.7 days (95%CI=95.1-138.3, I2=99.5, 
Q=4435.1). The Begg-Mazumdar (Kendall's tau b=0.18, p=0.215) and Egger test (t=4.31, 
df=24, p<0.001) indicated no publication bias.  
 
Subgroup analyses of LOS  
Stratified LOS during the follow-up period with heterogeneity and trim-and-fill analyses 
is provided in Table 3. The LOS was the longest in studies published from 1966-1995 (192.3 
days, 95%CI=129.7-254.8, I2=89.2, Q=37.1). The trim-and-fill method demonstrated that the 
average LOS in these studies was 216.8 days (95%CI=126.3-307.3) when adjusted for 
missing studies. The mean LOS appeared to decrease in more recent studies from 1996-2002 
(129.9 days, 95%CI=78.8-180.9, I2=98.9, Q=368.1) and 2003-2009 (97.7 days, 95%CI=55.3-
139.9, I2=99.8, Q=3041.4). The shortest average LOS was recorded in studies from 2010-
2017 (96.6 days, 95%CI=54.0-139.2, I2=99.3, Q=852.8).  
 
Effect of moderator variables influencing LOS 
Information on the moderators of LOS is presented in Table 4. The meta-regression 
analyses showed that a longer LOS was associated with Black ethnicity (β=2.905, 
95%CI=1.273-4.537, p<0.001, R2=0.14%) and longer DUP (mediandays) (β=0.303, 
95%CI=0.266-0.340, p<0.001, R2=0.11). Another significant moderator of a longer mean LOS 
was a longer length of follow-up (β=11.707, 95%CI=6.577-16.838, p<0.001, R2=0.21). Several 
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baseline factors associated with shorter average LOS were identified. A shorter average LOS 
was associated with White ethnicity (β=-0.181, 95%CI=-0.219- -0.143, p<0.001, R2=0.12), 
reduced severity of psychotic symptoms at baseline (β=-0.019, 95%CI=-0.036- -0.003, 
p=0.018, R2=0.08) and studies conducted in more recent years (β=-4.413, 95%CI=-7.456- -
1.370, p=0.004, R2=0.15).  
 
Discussion  
To our knowledge this is the first systematic review and meta-analysis to investigate the 
proportion of FEP cases who required hospitalisation at least once after their first contact with 
mental health services and the average LOS in hospital during follow-up. We found that more 
than half (55%) of all FEP patients required a hospitalisation over an average follow-up of 7 
years after FEP. This proportion may seem high, but is not surprising considering that only 
38% of FEP patients recover during follow-up (Lally et al., 2017), with 34% of FES patients 
meeting criteria for treatment resistance over a five year period (Lally et al., 2016).  
 
Hospitalisation and average LOS in FEP patients 
While bed capacity in psychiatric services has decreased in many developed countries 
since the 1950s (Raftery, 1992) supported by intensive attempts to integrate and care for 
people in the community (Munk-jorgensen, 1999), our findings demonstrate that the proportion 
of people with FEP who were admitted to hospital after their first contact with mental health 
services has remained stable over time. Nonetheless, in accordance with previous research 
(Agius et l., 2010; Hobbs et al., 2000; Leff and Trieman, 2000) we found that the average LOS 
in hospital for people FEP has decreased considerably over the past 20 years with the 
sharpest reduction observed in the last 7 years. This pattern was particularly pronounced in 
Australia and New Zealand. Our findings may indicate that while early intervention services 
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for psychosis are successful in facilitating earlier discharge from hospital (Agius et al., 2010); 
the sustained high proportion who require inpatient care over the illness course questions 
whether they are able to reduce the need for hospital admissions. Recent observational data 
indicate the benefits of antipsychotic long-acting injections and clozapine in reducing the need 
for hospitalisation in psychotic disorders (Tiihonen et al., 2017). Although we did not 
investigate the impact of antipsychotic long-acting injections and clozapine in reducing the 
need for hospitalisation in psychotic disorders in the present study, their wider use may be 
one route to reducing the sustained rates of hospitalisation identified in our study.  
We found that the number of cases who were hospitalised at least once during follow-
up did not differ significantly depending on the length of follow-up. Hospitalisation is 
considered an indicator of poor outcome in FEP (Lieberman et al., 1998; Schoeler et al., 2017) 
because it is costly and occurs when the illness becomes severe enough to warrant such an 
intervention (Pottick et al., 2000). Accordingly, it may be argued that the longitudinal illness 
trajectory of psychosis is not characterised by a deteriorating course for most patients 
(Zipursky and Agid, 2015) as previously thought (Ropcke and Eggers, 2005; Schmidt et al., 
1995). This is consistent with what was observed in relation to longitudinal recovery rates in 
patients with FEP where no evidence for worsening recovery rates with longer duration of 
follow up were found (Lally et al., 2017).  
We found that the proportion of patients hospitalised during follow-up was considerably 
higher in high-income compared to the middle-income countries. Although this might imply a 
more debilitating illness course in well-developed countries (Lin and Kleinman, 1988), it could 
also be explained by differences in social support and family support structures and quality of 
mental health-care in middle-income countries where the burden of care and treatment costs 
tend to fall on families rather than hospitals (Patel et al., 2007; Saxena et al., 2005). 
 
Impact of moderator variables on hospitalisation and LOS in FEP patients 
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The reasons for hospitalisation are complex (Schoeler et al., 2017) and likely to be 
explained by a range of clinical and social factors. Medication adherence was shown to be an 
important determinant for hospitalisation in patients with FEP during an 18 month follow-up 
study (Sfercu et al., 2017). However, this finding is not supported by studies with a longer 
follow-up period (Friis et al., 2016) including the present work. Comparable to previous reports 
(Immonen et al., 2017; Ingrid et al., 2000; Uggerby et al., 2011), which identified an association 
between a younger age of illness onset and increased hospitalisation, we found that an older 
age of illness onset was associated with reduced hospitalisation, though it was not a significant 
moderator for LOS. Consistent with previous literature highlighting associations between DUP 
and poorer outcomes in patients with psychosis (Harrigan et al., 2003; Schimmelmann et al., 
2008), we found that longer DUP was significantly associated with longer LOS. It has been 
shown that the mode of onset of first psychotic symptoms is one of the strongest predictors of 
the duration of DUP (Compton et al., 2008), with an insidious onset of psychotic symptoms 
associated with a longer DUP (Ajnakina et al., 2017). The type of clinical or non-clinical service 
with whom the first contact is made following onset of psychosis has been shown to be another 
important factor in determining the length of DUP (Bechard-Evans et al., 2007; Ghali et al., 
2013; Tanskanen et al., 2011). Thus, multiple clinical and service level factors, as well as 
social factors, are related to DUP, these need to be examined in more detail to ascertain the 
best ways to reduce the length of DUP, and potentially LOS. 
In the present study Black ethnicity appeared to be an important factor influencing 
hospitalisation and was associated with longer inpatient care during follow-up. Black ethnicity 
has consistently been highlighted as a risk factor for psychosis onset (Lally et al., 2016; Radua 
et al., 2018), and has been associated with the development of a treatment resistant course 
of illness (Lally et al., 2016). Evidence is emerging from the UK that the longitudinal trajectory 
of psychosis in patients of Black ethnicity is characterised by more extensive utilisation of 
psychiatric services compared with patients of White British ethnicity (Ajnakina et al., 2017; 
Morgan et al., 2014), results supported by the present study. Considering that patients of Black 
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ethnicity are also at risk of becoming increasingly socially disadvantaged as their illness 
progresses (Ajnakina et al., 2017; Morgan et al., 2014), the need for hospitalisation and 
prolonged inpatient stays in those of Black ethnicity observed in the present study may be 
related to social adversity.  
We found that being in a stable relationship at the time of first contact with FEP was 
associated with a reduced proportion of hospitalisation during follow-up. Being in a stable 
relationship may constitute improved social integration and strong social networks that have 
been shown to be associated with improved outcomes in FEP (Erickson et al., 1989). 
However, as it is common for individuals with psychosis to struggle to develop or maintain 
stable relationships (Sundermann et al., 2014), the protective effect of this factor may only be 
available to a minority of patients. Alternatively, being in a stable relationship may be indicative 
of a preserved premorbid level of functioning, improved outcomes and reduced 
hospitalisations during follow-up.  
 
Methodological considerations 
This is the first meta-analysis to investigate the proportion of FEP patients who required 
hospitalisation at least once after their first contact with mental health services and the average 
LOS in hospital during the entire follow-up period. We examined the proportion of hospitalised 
patients and average LOS during follow-up separately for baseline diagnosis of FEP, first 
episode schizophrenia and first episode affective disorders. Stratification by diagnosis allowed 
us to capture the most representative trajectory of illness for these diagnostic categories. 
Focusing on the incident sample of patients with a first presentation to services for psychosis 
ensured that the findings are not biased by chronicity of illness. 
Notwithstanding the strengths, there are several limitations to the data and meta-
analysis that warrant discussion. While we identified studies from five regions of the world, 
there was marked variability in the number of studies from each region, with the majority 
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conducted in Europe. We were unable to eliminate confounding variables relating to group 
differences in FEP cases that were enrolled in the different regions, and other service level 
confounds which may have existed between regions. This may include the variability in criteria 
employed that would warrant hospitalisation or prolonged hospital stays, bed availability, 
accessibility of community mental health services, treatment received in the community and 
in hospital, availability of community social supports, local mental health laws relating to 
involuntary hospital admission or other legal frameworks. Evidence suggests that all of these 
factors tend to vary between countries and regions (Burti, 2001; Saxena et al., 2006; Tulloch 
et al., 2012) and as such may have influenced hospitalisation and LOS across populations 
and studies included in the present meta-analysis. This should be taken into consideration 
when interpreting the study findings. Although it may be argued that studies utilising data from 
case notes may not have provided a reliable depiction of the clinical course of psychosis 
(Eaton et al., 1992), in the present study we found that hospitalisation and average LOS did 
not significantly differ depending on sources of data ascertainment. In relation to the meta-
regression analyses, some of the variables might have failed to achieve statistical significance 
because of a lack of power due to small sample sizes. Further, we did not obtain data on 
important confounders such as types of treatments received or services available, lifestyle 
factors such as substance use, and symptom profile over the course of follow-up precluding 
the meta-analytic assessment of these factors as moderating and/or mediating variables. By 
excluding hospitalisations that occurred at the first contact with mental health services for FEP 
we may have omitted a small proportion of severely ill patients who might have remained 
hospitalised for most of the follow-up period. Finally, we were unable to establish the reasons 
for hospitalisation, whether it was the result of psychotic relapse, antipsychotic intolerance or 
a comorbid mental disorder. 
 
Conclusion 
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This meta-analysis indicates that one in two patients with FEP will require hospitalisation 
at least once during a 7-year follow-up with an average inpatient stay of 4 months during this 
period. While the proportion of those with FEP who were admitted to hospital in the years 
following FEP has remained stable over the years, the average time FEP cases spent in 
hospital during follow-up has decreased in the last 20 years. This suggests that patients are 
now discharged earlier compared to previous time periods. While most patients and clinicians 
may favour shorter LOS in hospital, the question as to whether patients are discharged 
prematurely needs further investigation.  
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Figure Legends 
Figure 1. The flowchart of the article selection process in the meta-analysis of hospitalisation 
and length of hospital stay during follow-up in patients with first episode psychosis (FEP). 
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Table 1. Meta-analysis of proportion of patients with first episode psychosis who were hospitalised at least once during a follow-up period  
  Analysis Meta-analysis  Heterogeneity  Publication bias 
    
n studies 
Pooled 
prevalence 
(%) 
95% CI 
Between group 
p-value 
 I2 Q-value p-value  
Trim and fill 95% CI 
[N studies trimmed] 
Proportion of patients who were 
hospitalised at least once  
58 55.4 50.3 60.5   98.5 3575.1 <0.001  Unchanged 
               
Study year group     0.191       
  1966-1996 17 63.2 53.6 72.9   92.9 231.1 <0.001  Unchanged 
  1997-2005 16 47.6 36.5 58.8   96.1 490.6 <0.001  Unchanged 
  2006-2011 17 56.1 45.0 67.2   99.3 1743.7 <0.001  Unchanged 
  2012-2017  8 46.6 30.7 62.5   98.2 564.4 <0.001  Unchanged 
  
 
           
Study region     0.013       
  Asia 6 32.5 23.5 41.4   81.4 39.7 <0.001  Unchanged 
  Australia and New Zealand 3 78.4 59.2 97.5   98.4 203.7 <0.001  Unchanged 
  Europe 38 58.1 50.7 65.5   97.1 1212.1 <0.001  Unchanged 
  North America 9 48.0 34.5 61.6   95.4 213.6 <0.001  Unchanged 
  Middle East  1 64.0 63.1 64.9   0.0 0.0 1.000  N/A 
 Multicentre 1 21.0 15.69 26.23   0.0 0.0 1.000  N/A 
             
Assessment type     0.106       
  Case notes 18 62.5 52.1 72.9   99.2 1541.3 <0.001  Unchanged 
  Interview 32 52.7 44.6 60.7   96.3 1047.5 <0.001  Unchanged 
  Combination of both approaches  7 43.3 26.7 60.0   97.6 413.8 <0.001  Unchanged 
              
Study settings     0.659       
  In-/out-patient psychiatric services 20 57.1 46.4 67.7   98.6 1557.4 <0.001  Unchanged 
  Adult psychiatric hospitals 34 54.0 43.4 59.2   97.4 908.1 <0.001  Unchanged 
  Community & early intervention 
services 
4 45.0 22.1 67.8   98.9 420.3 <0.001  Unchanged 
  
 
           
Length of follow-up categories     0.388       
  1-2 years 17 47.9 36.0 59.7   98.3 2155.2 <0.001  52.7 (40.3-65.0) [2] 
  3-5 years 14 56.9 46.2 67.6   96.2 450.9 <0.001  Unchanged 
  ≥6 years 27 57.4 48.3 66.48   98.5 859.1 <0.001  Unchanged 
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Country socioeconomic status     0.010       
  High income 50 57.9 51.7 64.1   98.4 2833.6 <0.001  Unchanged 
  Middle income 7 34.8 20.0 49.6   96.0 355.8 <0.001  42.9 (27.4-56.5) [2] 
             
Baseline diagnoses      0.930       
  FEP 22 55.9 45.7 66.1   98.0 2351.3 <0.001  Unchanged 
  FES 35 53.5 45.7 61.3   98.0 948.4 <0.001  Unchanged 
 FEAP 1 54.2 34.2 74.1   0.0 0.0 1.000  NA 
n, number; FEP, first episode psychosis; FU, follow up period; FEAP, first episode affective psychosis; N/A, not appropriate; CI, confidence 
intervals.  
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Table 2. Meta regression of moderators of proportion of patients with first episode psychosis 
who were hospitalised at least once during a follow-up  
 
Number of 
comparison 
β 95% CI p-value R² 
Moderators       
Demographic factors       
  Age (mean) at onset  15 0.060 -0.002 0.122 0.058 0.04 
 Age (mean) at first contact  41 -0.049 -0.092 -0.005 0.028 0.07 
  Males (%) 56 0.001 -0.004 0.006 0.762 0.00 
  White (%) 16 0.002 -0.002 0.005 0.344 0.00 
  Black (%) 16 0.004 0.000 0.009 0.075 0.13 
  Asian (%) 13 -0.002 -0.005 0.001 0.164 0.07 
          
Clinical presentation and treatment       
  Baseline psychotic symptoms(mean) 14 0.000 -0.005 0.005 0.935 0.00 
  Duration of untreated psychosis (days-mean) 12 0.000 -0.001 0.000 0.732 0.00 
  Duration of untreated psychosis (days-median) 8 -0.001 -0.003 0.001 0.202 0.09 
  Taking antipsychotic medications at baseline (%) 15 0.000 -0.003 0.004 0.934 0.00 
  Taking antipsychotic medications at follow up (%) 27 -0.002 -0.007 0.003 0.383 0.00 
  Compliance with antipsychotic medications during FU (%) 10 0.004 -0.002 0.010 0.185 0.08 
          
Social factors        
  Employed at baseline (%) 16 -0.002 -0.008 0.004 0.555 0.00 
  Single at baseline (%) 23 0.003 -0.002 0.008 0.203 0.03 
  Stable relationship at baseline 19 -0.011 -0.018 -0.004 0.004 0.33 
        
Other factors        
  Drop-out 54 -0.003 -0.007 0.000 0.080 0.04 
  Length of follow up 58 0.004 -0.006 0.013 0.488 0.00 
  Study year publication 58 -0.004 -0.010 0.002 0.161 0.02 
DUP, duration of untreated psychosis; β, beta coefficient; CI, confidence intervals  
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Table 3. Meta-analysis of length of inpatient stays during a follow-up in patients with first episode psychosis 
  Analysis Meta-analysis 
 
Heterogeneity 
 
Publication bias 
    
n studies Pooled mean 95% CI 
Between group 
p-value 
 I2 Q-value p-value  
Trim and fill 95% CI 
[N studies trimmed] 
Average length of inpatient stay during a 
follow-up  
26 116.7 95.1 138.3   99.5 4435.1 <0.001  Unchanged 
               
Study year group     0.058       
  1966-1995 5 192.3 129.7 254.8   89.2 37.1 <0.001  216.8 (126.3-307.3) [1] 
  1996-2002 5 129.9 78.8 180.9   98.9 368.1 <0.001  Unchanged 
  2003-2009 7 97.7 55.3 139.9   99.8 3041.4 <0.001  126.0 (54.0-197.0) [1] 
  2010-2017  7 96.6 54.0 139.2   99.3 852.8 <0.001  94.6 (67.2-121.9) [1] 
  
 
           
Study region     0.326       
  Asia 4 71.1 -25.6 167.7   99.0 349.4 <0.001  60.2 (28.8-91.7) [1] 
  Australia and New Zealand 1 25.9 -167.2 219.0   0.0 0.0 1.000  N/A 
  Europe 18 145.7 99.2 192.2   99.6 2416.1 <0.001  Unchanged 
  North America 3 175.0 47.5 302.5   99.8 51.6 <0.001  Unchanged 
               
Assessment type     0.798       
  Case notes 3 114.2 54.9 173.5   98.0 101.3 <0.001  Unchanged 
  Interview 20 119.3 95.0 143.5   99.5 3967.9 <0.001  Unchanged 
  Combination of both approaches  1 83.1 -20.7 186.9   0.0 0.0 1.000  N/A 
              
Study settings     0.794       
  In-/out-patient psychiatric services 11 114.9 81.1 148.6   99.7 3573.1 <0.001  Unchanged 
  Adult psychiatric hospitals 11 128.6 92.1 165.2   98.3 596.3 <0.001  Unchanged 
  Community & early intervention 
services 
1 92.8 -18.2 203.8   0.0 0.0 1.000  N/A 
  
 
           
Country socioeconomic status      0.178       
  High income 23 120.5 97.7 143.3   99.5 4433.8 <0.001  Unchanged 
  Middle income 1 47.8 -55.6 151.2   0.0 0.0 1.000  N/A 
             
Baseline diagnoses      0.345       
  FEP 8 103.8 33.8 173.8   99.8 658.4 <0.001  Unchanged 
  FES 15 159.5 106.2 212.7   99.8 2164.0 <0.001  Unchanged 
 FEAP 2 81.8 -58.4 222.0   96.3 27.3 <0.001  N/A 
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n, number; FEP, first episode psychosis; FU, follow up period; FEAP, first episode affective psychosis; N/A, not appropriate; CI, confidence 
intervals 
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Table 4. Meta-regression of moderators of an average length of inpatient stay during a follow-up during a follow up in patients with first episode 
psychosis 
 Number of 
comparison 
β 95% CI p-value R² 
Moderators       
Demographic factors       
 Age (mean) at onset  11 3.604 -1.039 8.246 0.128 0.00 
 Age (mean) at first contact  15 5.150 -1.212 11.512 0.113 0.00 
 Males (%) 20 -0.566 -3.049 1.916 0.655 0.00 
 White (%) 8 -0.181 -0.219 -0.143 0.000 0.12 
 Black (%) 5 2.905 1.273 4.537 0.000 0.14 
 Asian (%) 4 0.072 -0.507 0.651 0.808 0.00 
        
Clinical presentation and treatment       
 Baseline psychotic symptoms(mean) 10 -0.019 -0.036 -0.003 0.018 0.08 
 Duration of untreated psychosis (days-mean) 9 -0.005 -0.158 0.149 0.953 0.00 
 Duration of untreated psychosis (days-median) 4 0.303 0.266 0.340 0.000 0.11 
 Taking antipsychotic medications at baseline (%) 4 1.289 -0.804 3.383 0.227 0.00 
 Taking antipsychotic medications at follow up (%) 8 1.249 -1.756 4.254 0.415 0.00 
 Compliance with antipsychotic medications during FU (%) 3 1.910 -1.281 5.177 0.237 0.17 
        
Social factors        
 Employed at baseline (%) 5 2.137 -1.010 5.284 0.183 0.00 
 Single at baseline (%) 7 -1.747 -4.776 1.282 0.258 0.01 
 Stable relationship at baseline 5 5.930 -4.082 15.942 0.246 0.00 
        
Other factors        
 Drop-out 22 1.091 0.033 2.149 0.043 0.10 
 Length of follow up 22 11.707 6.577 16.838 0.000 0.21 
 Study year publication 22 -4.413 -7.456 -1.370 0.004 0.15 
DUP, duration of untreated psychosis; β, beta coefficient; CI, confidence intervals  
 
 
